HIV-1 envelope subregion length variation during disease progression - Wikidata - awgldk - TriplyDB

HIV-1 envelope subregion length variation during disease progression

HIV-1 envelope subregion length variation during disease progression

http://www.wikidata.org/entity/Q30397933

about

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses Identification of a cluster of HIV-1 controllers infected with low replicating viruses The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Phenotypic properties of transmitted founder HIV-1 Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users HIV-1 envelope glycoprotein variable loops are indispensable for envelope structural integrity and virus entry.HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon.Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients.Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.Neutralizing antibodies and control of HIV: moves and countermoves.Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.HIV-1 diversity in the envelope glycoproteins: implications for viral entry inhibition.The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development.Efficiency of neutralizing antibodies targeting the CD4-binding site: influence of conformational masking by the V2 loop in R5-tropic clade C simian-human immunodeficiency virus.Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.Host and Viral Factors in HIV-Mediated Bystander Apoptosis.Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1.High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.

P2860

Q28082862-BBDD2744-6B7B-4DB8-8ECB-2EE8EC590987 Q28534737-74DBD8A8-9B66-4E8D-9305-1AD8C84A7D3C Q30152923-1EFFE9FB-534B-4CDC-B092-C7B3BADBE316 Q30353580-ECCC4EE8-0B83-4E2A-9C08-356461B8E780 Q30363755-6AD444BB-C06E-4FF9-AED0-E800D2A59E68 Q30393763-94AF674E-BA45-4780-BEE3-8C6E6CC808CF Q33592001-2E25923A-74E4-4D7B-B909-29BFE92922A2 Q34029430-14C257D1-2BAC-4F57-9181-06C17EDC029B Q34200095-545C9287-97EC-443F-BF99-EACFC7285AA8 Q34309493-F39D3BDC-DA35-40E7-B534-35C3FA172988 Q34336058-0BFB0290-0FB6-420A-BA08-AA18B8E87D06 Q34407843-3C68BC86-6669-4B05-9FE5-21DBE2E117C0 Q34620235-19E6C5D1-2D21-4E62-84BC-AEFA359889D1 Q34924647-02074253-D057-4E72-AAB5-FC85595DF246 Q35113720-447AEA70-CF48-43A1-8891-C50981DB8E62 Q35161426-629FE54D-33F7-499F-8EDC-002B556DCB53 Q35192915-FEF99C90-CB28-4854-8FEB-92EB2156E0D1 Q35216488-9F18199C-7EB8-4048-A32A-621618931E3B Q35826458-D6F2E0D7-E311-4659-B00D-B76E0CF7DF09 Q35943521-7E7172A9-7360-4D0E-B691-54899172EB3D Q36000722-8AADE562-6830-46B4-AE81-CDD149B27881 Q36081789-14D04E6C-6D79-45A5-A06A-D179720A2D03 Q36246353-A30A4E77-6D62-4393-B72D-5BF76C983CF2 Q36306344-0E735F8D-3749-4E67-82EC-2BFE20B52057 Q36553805-87FCAF41-E351-47F6-B7A3-66CB69B9A9FE Q36978861-610E7231-6B33-4EDF-AFD1-C4975DC4F4E7 Q37233074-CF468963-A4B7-465E-9F25-767D0D409DE1 Q37252966-8829DE5C-9E3C-4BEE-8E44-CAB17F447244 Q37360774-B3D6F305-BFC0-49DF-A254-EFE918E33794 Q37536431-DE040077-38A0-47C0-A84C-03A28D01836D Q37971867-8D53DCA7-1F45-4C9B-8784-C994A34D3CD0 Q38046828-166C03EF-656A-40CD-A552-19C3F5F16DFD Q38079744-5B10E9B7-6CCB-4F25-A834-D1917B2924C9 Q38243948-E832F907-465E-46FF-B266-E172DA41E51A Q38961133-81571621-D5B4-4466-9542-B6B5C244377F Q39398170-408A4FAF-1E3C-4ACC-93C7-FABAF07D94C3 Q40075506-3626DEBD-1124-4894-AA30-02F8175412D3 Q40174150-526CE993-2CDE-4F0E-846D-0983E7BC2DE4 Q40238313-C920C903-828E-453A-AF3C-CB857EC38A12 Q40548483-F00E373B-7EAE-4D52-AC7E-398A88BCE7E8

P2860

HIV-1 envelope subregion length variation during disease progression

http://www.wikidata.org/entity/Q30397933

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

HIV-1 envelope subregion length variation during disease progression

@ast

HIV-1 envelope subregion length variation during disease progression

@en

type

label

HIV-1 envelope subregion length variation during disease progression

@ast

HIV-1 envelope subregion length variation during disease progression

@en

prefLabel

HIV-1 envelope subregion length variation during disease progression

@ast

HIV-1 envelope subregion length variation during disease progression

@en

P1433

Q30397933-B5C93465-58C9-4309-A62D-D69DF2A98BCE

P1476

Q30397933-60BA8691-DD4B-498F-A7FF-CE38E35E2211

P2093

Q30397933-1A2C76AD-9873-4199-874B-C4404786AC83

Q30397933-1D108E18-C67F-4185-9B51-3F1A372F8606

Q30397933-2EF5BF83-08F1-4660-AD42-0C4D6592011E

Q30397933-6B88A478-E00D-4B6D-9FE1-30E2DD172614

Q30397933-95BB248A-522C-4AB4-BD91-770FE2EEAF43

Q30397933-F51BB637-FA27-4042-94F4-4756B9B7CE8F

Q30397933-FBB6DD62-9F7C-4EE5-B6E7-C2BE9E74C55E

P2860

Q30397933-00573985-B9FE-4CA5-8BB2-E95A030E3CEE

Q30397933-054F9BD4-A2CE-4A61-BC9F-A909F9523B6A

Q30397933-0C7C9F02-2600-4FDC-AA3F-1AC95342BEC5

Q30397933-10063FB8-4F91-4DDD-A363-134B97B1A352

Q30397933-1274862D-B229-4F5A-9D29-40D068D005BE

Q30397933-12A90569-03CE-41E2-A990-3E9E721A8295

Q30397933-150D94BF-F69A-47EE-8D84-AEF26345B296

Q30397933-1B0FAC1C-B83C-46C4-957E-2B72A898E401

Q30397933-201EAE12-6A1C-4C30-9747-7CEFE5943543

Q30397933-217EBAE9-896B-4604-A092-8BC65A9A27BE

P304

Q30397933-24430301-A00E-4BE4-B51B-C113C93BDDD0

P31

Q30397933-E8454D48-0E80-4F16-8855-E141CFC7869B

P356

Q30397933-E985C3EA-0949-4675-925E-2BC160780FAE

P433

Q30397933-8A3B96E3-AEA9-4044-BBDC-BFEE09399B26

P478

Q30397933-2A38AD9E-B40E-462C-8EED-750758EC6BBB

P50

Q30397933-F1117055-A42B-4A78-8682-48BBB630DE8A

P577

Q30397933-A8F30CD2-D178-4B21-9B13-8B008719B231

P5875

Q30397933-D8544912-268B-4A40-B717-AA336C5B5E1B

P698

Q30397933-117E9C9D-F55D-4E9C-B505-C9B028C413C8

P932

Q30397933-823E5003-A283-4C03-B4E1-B1F40EF86EBA

P356

JOURNAL.PPAT.1001228

P1433

P1476

HIV-1 envelope subregion length variation during disease progression

@en

P2093

James I Mullins

http://www.w3.org/2001/XMLSchema#string

Marcel E Curlin

http://www.w3.org/2001/XMLSchema#string

Rafael Zioni

http://www.w3.org/2001/XMLSchema#string

Stephen E Hawes

http://www.w3.org/2001/XMLSchema#string

Tuofu Zhu

http://www.w3.org/2001/XMLSchema#string

Wenjie Deng

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

P2860

HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

Longitudinal data analysis for discrete and continuous outcomes

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

P304

e1001228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1001228

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey S. Gottlieb

P577

2010-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49711373

http://www.w3.org/2001/XMLSchema#string

P698

21187897

http://www.w3.org/2001/XMLSchema#string

P932

3002983

http://www.w3.org/2001/XMLSchema#string